您的位置: 首页 > 农业专利 > 详情页

Novel hydantoin derivative and medicine using the same as effective ingredients
专利权人:
KYORIN PHARMACEUTICAL CO.; LTD.
发明人:
SATO, TARO,佐藤太朗,佐藤太朗,KOMINE, TAKASHI,小峰隆史,小峰隆史,RENBUTSU, MAKOTO,连佛诚,連佛誠,KOBAYASHI, NAOKI,小林直树,小林直樹
申请号:
TW100130372
公开号:
TW201212913A
申请日:
2011.08.24
申请国别(地区):
TW
年份:
2012
代理人:
摘要:
The present invention provides a compound with stronger AMPK (adenosine monophosphate-activated protein kinase) activation effect, and exhibits beneficial effect originated from AMPK activation effect in living bodies, and also presents excellent hypoglycemic and hypolipidemic effects in living bodies. The present invention relates to a hydantoin derivatives represented by general formula (1), or a pharmacologically permissible salt or a hydrate for the same. The present invention may be applied as a human AMPK activation drug and provide effective treatment for lipid metabolism disorder or diabetes.本發明提供一種具有較強之AMPK活化作用且於生物體內表現出源自AMPK活化作用之有利效果的化合物。本發明係關於一種通式(1)所表示之乙內醯脲衍生物或其藥理上所容許之鹽或該等之水合物。[化1]
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充